Dearborn Partners’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-483
| Closed | -$299K | – | 274 |
|
|
2024
Q3 | $299K | Buy |
483
+4
| +0.8% | +$2.47K | 0.01% | 224 |
|
|
2024
Q2 | $265K | Buy |
479
+115
| +32% | +$63.6K | 0.01% | 230 |
|
|
2024
Q1 | $212K | Sell |
364
-66
| -15% | -$38.4K | 0.01% | 256 |
|
|
2023
Q4 | $228K | Buy |
430
+29
| +7% | +$15.4K | 0.01% | 240 |
|
|
2023
Q3 | $203K | Sell |
401
-12
| -3% | -$6.07K | 0.01% | 232 |
|
|
2023
Q2 | $215K | Buy |
413
+7
| +2% | +$3.65K | 0.01% | 225 |
|
|
2023
Q1 | $234K | Sell |
406
-456
| -53% | -$263K | 0.01% | 219 |
|
|
2022
Q4 | $475K | Buy |
862
+330
| +62% | +$182K | 0.02% | 161 |
|
|
2022
Q3 | $270K | Buy |
532
+10
| +2% | +$5.08K | 0.01% | 202 |
|
|
2022
Q2 | $284K | Hold |
522
| – | – | 0.01% | 203 |
|
|
2022
Q1 | $308K | Buy |
522
+83
| +19% | +$49K | 0.01% | 204 |
|
|
2021
Q4 | $293K | Hold |
439
| – | – | 0.01% | 220 |
|
|
2021
Q3 | $251K | Hold |
439
| – | – | 0.01% | 217 |
|
|
2021
Q2 | $221K | Buy |
+439
| New | +$221K | 0.01% | 237 |
|
|
2015
Q3 | – | Sell |
-2,471
| Closed | -$321K | – | 217 |
|
|
2015
Q2 | $321K | Sell |
2,471
-3,056
| -55% | -$397K | 0.03% | 183 |
|
|
2015
Q1 | $743K | Sell |
5,527
-42
| -0.8% | -$5.65K | 0.07% | 188 |
|
|
2014
Q4 | $698K | Buy |
5,569
+275
| +5% | +$34.5K | 0.06% | 191 |
|
|
2014
Q3 | $644K | Buy |
+5,294
| New | +$644K | 0.06% | 192 |
|